Key PointsPrestige Consumer Healthcare is quietly building a stronger OTC healthcare empire. Its $1.045 billion acquisition of Breathe Right, along with Dimetapp and Anbesol, expands its portfolio of category-leading brands and gives it new growth opportunities in sleep, allergy, and wellness.Investors should watch whether management can successfully integrate acquisitions and reduce its elevated debt over the next few years.10 stocks we like be…